Elarex Inc. is a Canadian healthcare technology company commercializing its proprietary PT120 formulation technology which has proven to stabilize biologicals (including live vaccines!) so that they are as effective when stored at 40C as if they had been stored at -80C.
The Elarex PT120 Formulation Technology has many merits. The most startling? Live attenuated vaccines formulated with PT120 have equivalent performance after storage at 40C as unformulated vaccine stored at -80C. That’s 120 degrees of stabilization.
The final product form is highly customizable including powders and coatings. We aim to partner with vaccine leaders, to help improve your products. Our vision is a future where vaccines will not need refrigeration.